Skip to main content
. 2017 Sep 12;24:56–63. doi: 10.1016/j.ebiom.2017.09.007

Table 1.

Results for measurement of plasma Hsp90α, AFP, or both in the diagnosis of hepatocellular carcinoma (HCC), or early-stage HCC.

AUC (95%CI) Cutoff (ng/mL) Sensitivity (%) Specificity (%) PPV (%) NPV (%) Positive LR Negative LR
HCC vs Non-LC
Hsp90α 0.965(0.953–0.976) 62.44 93.32 90.27 87.32 95.04 9.64 0.07
AFP20a 0.887(0.866–0.907) 6.98 75.05 92.34 91.17 77.95 9.86 0.27
Hsp90α + AFP 0.977(0.968–0.985) 93.70 94.40 91.91 95.63 14.69 0.07



HCC vs At-risk
Hsp90α 0.938(0.910–0.967) 73.23 89.00 90.20 96.53 72.64 8.96 0.12
AFP20a 0.851(0.820–0.883) 6.171 76.82 83.01 93.54 52.23 4.44 0.28
Hsp90α + AFP 0.952(0.930–0.975) 94.10 88.90 96.57 82.25 8.64 0.07



Early-stage HCC vs Non-LC
Hsp90α 0.962(0.949–0.974) 62.44 92.41 90.27 83.52 95.72 9.54 0.08
AFP20a 0.875(0.851–0.898) 6.98 72.66 92.34 88.58 80.61 9.54 0.30
Hsp90α + AFP 0.974(0.964–0.983) 92.70 94.4 91.13 94.06 16.68 0.08



Early-stage HCC vs At-risk
Hsp90α 0.935(0.905–0.964) 73.23 87.34 90.20 95.29 75.12 8.76 0.14
AFP20a 0.833(0.798–0.868) 6.17 74.43 83.01 91.59 56.09 4.30 0.31
Hsp90α + AFP 0.949(0.925–0.972) 92.70 88.90 95.56 82.74 8.50 0.08

HCC indicates hepatocellular carcinoma. Non-LC indicates non-liver cancer control. At-risk indicates non-cancerous liver diseases, including hepatitis, liver cirrhosis, focal nodular hyperplasia. Early-LC indicates patients with early-stage liver cancer. Hsp90α + AFP indicates the combined diagnosis with these two proteins. AUC represents area under curve. CI indicates confidence interval. Early-stage HCC represents patients with early-stage hepatocellular carcinoma. Hsp90α indicates heat shock protein 90alpha. AFP means α-fetoprotein. AUC represents area under curve. HC for healthy controls. PPV indicates positive predictive value. NPV means negative predictive value. LR represents likelihood ratio.

a

The commonly used cutoff value for AFP in HCC diagnosis.